Originally published by our sister publication Specialty Pharmacy Continuum
By Myles Starr
The Substance Abuse and Mental Health Services Administration (SAMHSA), a division of the Department of Health and Human Services, published new rules comprehensively updating regulations governing opioid treatment programs (OTPs). Key to these rules is making the COVID-19–era emergency flexibility permanent for remote prescribing of methadone and buprenorphine.
“This is something that many of us